Updated Clinical Guidelines for Surgical Treatment of Chronic Rhinosinusitis in Adults
New clinical guidelines from the American Academy of Otolaryngology provide evidence-based recommendations for the surgical treatment of chronic rhinosinusitis in adults, emphasizing diagnosis, patient expectations, and personalized surgical planning.
A new set of clinical practice guidelines has been released by the American Academy of Otolaryngology-Head and Neck Surgery Foundation, offering comprehensive recommendations for the surgical management of chronic rhinosinusitis in adult patients. Published online on May 27 in Otolaryngology-Head and Neck Surgery, these guidelines aim to assist clinicians in making evidence-based decisions to improve patient outcomes.
Led by Dr. Jennifer J. Shin from Harvard Medical School, a panel of experts formulated 11 key action statements. These emphasize the importance of confirming a diagnosis of chronic rhinosinusitis prior to considering surgery. Notably, they advise against mandating a specific medical therapy regimen or trial duration before opting for surgical intervention. Patients with certain subtypes of rhinosinusitis—such as those with nasal polyps, polyps with bony erosion, eosinophilic mucin, or fungal balls—are highlighted as ideal surgical candidates who might benefit more from operative procedures than continued medical therapy.
The guidelines stress the importance of setting realistic expectations through thorough preoperative counseling. Patients should be informed about the potential for ongoing symptoms or disease recurrence, and the likelihood of requiring long-term medical management. Before surgery, a detailed computed tomography (CT) scan with fine-cut protocols is recommended to assess the sinuses and guide surgical planning. The extent of surgery should not be based solely on arbitrary imaging criteria like mucosal thickening or sinus opacification but should be tailored to individual patient anatomy and disease presentation.
Furthermore, patient education regarding postoperative care, including pain management, is essential. Dr. Shin emphasizes that these guidelines aim to streamline care pathways and support clinicians in delivering optimal treatment based on the latest evidence.
For more detailed information, consult the full guideline: DOI: 10.1002/ohn.1287. The guidelines are part of ongoing efforts to standardize and improve the surgical management of chronic rhinosinusitis in adults.
[Source: https://medicalxpress.com/news/2025-06-guidelines-issued-surgical-chronic-rhinosinusitis.html]
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Protein Cleavage Unveils Dual Functions in Childhood Ciliopathies and Cell Signaling
New research reveals how a specific cleavage of the TMEM67 protein separates its functions in cilia formation and cell signaling, offering insights into ciliopathies like Meckel-Gruber syndrome and potential therapeutic avenues.
Potential of Anti-Malarial Drugs in Promoting Weight Loss: New Research Findings
Research reveals that anti-malarial drugs like halofuginone may help promote weight loss by regulating appetite and energy metabolism through GDF15 and FGF21 pathways. This innovative approach, rooted in traditional Chinese medicine, offers promising new options for obesity treatment.
New Treatment Regimen Extends Blood Cancer Remission by Seven Months
A groundbreaking clinical trial has demonstrated that a new combination therapy can extend remission in multiple myeloma patients by an average of seven months, improving quality of life and offering new hope for treatment.